Special Issue "New Advances in Personalized Tissue Engineering: A Focus on Bone, Cartilage, and Blood Vessel Regeneration"
Deadline for manuscript submissions: 20 January 2024 | Viewed by 90
Tissue engineering holds immense potential for regenerative medicine, aiming to restore various damaged tissues. However, achieving optimal outcomes through standard treatments remains challenging due to the intricate, patient-specific nature of tissue regeneration. Personalized tissue engineering can bridge this gap.
In this Special Issue, we will delve into three tissue types:
- Bone: Bone tissue engineering addresses the high demand for bone grafts in various conditions. Personalized strategies can enhance graft integration and outcomes.
- Cartilage: Cartilage's avascular nature makes regeneration difficult. Personalized tissue engineering offers solutions for patient-specific conditions like osteoarthritis.
- Blood Vessels: Personalized blood vessel tissue engineering caters to the distinct graft requirements of cardiovascular disease patients, considering diverse diameters and properties.
Personalization in tissue engineering can be seen in various stages, such as tissue defect imaging, structural design, biomaterial development, fabrication methods, and cell seeding. Each plays a unique role in delivering patient-specific treatment.
This Special Issue will present cutting-edge developments in Personalized Tissue Engineering for these areas. Content will include original research, reviews, and communications. Our goal is to deepen the understanding of personalization in tissue engineering and provide insights for future clinical applications.
Dr. Juncen Zhou
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Journal of Personalized Medicine is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
- tissue engineering
- regenerative medicine
- blood vessels
- in vivo